KM-001
Palmoplantar Keratoderma, Olmsted Syndrome, Ichthyosis
Phase 1Active
Key Facts
Indication
Palmoplantar Keratoderma, Olmsted Syndrome, Ichthyosis
Phase
Phase 1
Status
Active
Company
About Kamari Pharma
TRPV3 inhibitor biotech focused on rare dermatologic disorders.
View full company profile